Style | Citing Format |
---|---|
MLA | Ashtari F, et al.. "The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic." Multiple Sclerosis and Related Disorders, vol. 92, no. , 2024, pp. -. |
APA | Ashtari F, Mehdipour R, Asgari M, Ghalamkari A (2024). The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic. Multiple Sclerosis and Related Disorders, 92(), -. |
Chicago | Ashtari F, Mehdipour R, Asgari M, Ghalamkari A. "The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic." Multiple Sclerosis and Related Disorders 92, no. (2024): -. |
Harvard | Ashtari F et al. (2024) 'The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic', Multiple Sclerosis and Related Disorders, 92(), pp. -. |
Vancouver | Ashtari F, Mehdipour R, Asgari M, Ghalamkari A. The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic. Multiple Sclerosis and Related Disorders. 2024;92():-. |
BibTex | @article{ author = {Ashtari F and Mehdipour R and Asgari M and Ghalamkari A}, title = {The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic}, journal = {Multiple Sclerosis and Related Disorders}, volume = {92}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Ashtari F AU - Mehdipour R AU - Asgari M AU - Ghalamkari A TI - The Correlation Between Rituximab Dose Reduction and Acute Relapses of Neuromyelitis Optica Spectrum Disorder, Lessons From Covid-19 Epidemic JO - Multiple Sclerosis and Related Disorders VL - 92 IS - SP - EP - PY - 2024 ER - |